Evidence map›Paper›PMID 41081207›Full record

ArticleQuantitative imaging in medicine and surgery2025

Clinical value of

Na Han, Jiao Li, Chenghui Lu, Zengmei Si, Yingying Zhang, Guoqiang Wang, Xinfeng Liu, Congcong Wang, Fengqi Li, Xufu Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Na Han *Department of Nuclear Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.
Jiao Li *Department of Nuclear Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.
Chenghui LuDepartment of Nuclear Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.
Zengmei SiDepartment of Nuclear Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.
Yingying ZhangDepartment of Nuclear Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.
Guoqiang WangDepartment of Nuclear Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.
Xinfeng LiuDepartment of Nuclear Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.
Congcong WangDepartment of Nuclear Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.
Fengqi LiDepartment of Nuclear Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.
Xufu WangDepartment of Nuclear Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The 2015 American Thyroid Association (ATA) guidelines indicate that patients with stimulated thyroglobulin (sTg) ≥10 ng/mL may need further evaluations. It has been reported that Technetium- Methods: In this study, 195 patients with DTC with sTg ≥10 ng/mL before initial RAIT were enrolled. The images of Results: The diagnostic sensitivity (χ Conclusions:

Indexed as

Differentiated thyroid carcinomaradioiodine therapyTechnetium-99m-methoxyisobutylisonitrile scintigraphy (99mTc-MIBI scintigraphy)thyroglobulin

Identifiers

PMID41081207
PMCPMC12514741

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.